Literature DB >> 28291648

Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.

Daniela P Sequeira1, Ricardo Correia1, Manuel J T Carrondo2, António Roldão3, Ana P Teixeira4, Paula M Alves1.   

Abstract

Safer and broadly protective vaccines are needed to cope with the continuous evolution of circulating influenza virus strains and promising approaches based on the expression of multiple hemagglutinins (HA) in a virus-like particle (VLP) have been proposed. However, expression of multiple genes in the same vector can lead to its instability due to tandem repetition of similar sequences. By combining stable with transient expression systems we can rationally distribute the number of genes to be expressed per platform and thus mitigate this risk. In this work, we developed a modular system comprising stable and baculovirus-mediated expression in insect cells for production of multi-HA influenza enveloped VLPs. First, a stable insect High Five cell population expressing two different HA proteins from subtype H3 was established. Infection of this cell population with a baculovirus vector encoding three other HA proteins from H3 subtype proved to be as competitive as traditional co-infection approaches in producing a pentavalent H3 VLP. Aiming at increasing HA expression, the stable insect cell population was infected at increasingly higher cell concentrations (CCI). However, cultures infected at CCI of 3×106cells/mL showed lower HA titers per cell in comparison to standard CCI of 2×106cells/mL, a phenomenon named "cell density effect". To lessen the negative impact of this phenomenon, a tailor-made refeed strategy was designed based on the exhaustion of key nutrients during cell growth. Noteworthy, cultures supplemented and infected at a CCI of 4×106cells/mL showed comparable HA titers per cell to those of CCI of 2×106cells/mL, thus leading to an increase of up to 4-fold in HA titers per mL. Scalability of the modular strategy herein proposed was successfully demonstrated in 2L stirred tank bioreactors with comparable HA protein levels observed between bioreactor and shake flasks cultures. Overall, this work demonstrates the suitability of combining stable with baculovirus-mediated expression in insect cells as an efficient platform for production of multi-HA influenza VLPs, surpassing the drawbacks of traditional co-infection strategies and/or the use of larger, unstable vectors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioprocess optimization; Hemagglutinin-based vaccine; Modular strategy; Multivalent influenza virus-like particles; Scale-up; Stable insect cells

Mesh:

Substances:

Year:  2017        PMID: 28291648     DOI: 10.1016/j.vaccine.2017.02.043

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Recombinant Protein Production and Purification of Insoluble Proteins.

Authors:  Neus Ferrer-Miralles; Paolo Saccardo; José Luis Corchero; Elena Garcia-Fruitós
Journal:  Methods Mol Biol       Date:  2022

2.  Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.

Authors:  Bárbara Fernandes; Ricardo Correia; Paula M Alves; António Roldão
Journal:  Front Bioeng Biotechnol       Date:  2022-06-29

3.  Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.

Authors:  Zachary R Sia; Matthew S Miller; Jonathan F Lovell
Journal:  Mol Pharm       Date:  2020-08-17       Impact factor: 4.939

Review 4.  Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach.

Authors:  Titus Abiola Olukitibi; Zhujun Ao; Mona Mahmoudi; Gary A Kobinger; Xiaojian Yao
Journal:  Microorganisms       Date:  2019-09-29

5.  Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens.

Authors:  Dexin Kong; Taoran Chen; Xiaolong Hu; Shaorong Lin; Yinze Gao; Chunmei Ju; Ming Liao; Huiying Fan
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

6.  Purification of influenza virus-like particles using sulfated cellulose membrane adsorbers.

Authors:  Sofia B Carvalho; A Raquel Fortuna; Michael W Wolff; Cristina Peixoto; Paula M Alves; Udo Reichl; Manuel Jt Carrondo
Journal:  J Chem Technol Biotechnol       Date:  2017-12-16       Impact factor: 3.174

Review 7.  Synthetic biology for bioengineering virus-like particle vaccines.

Authors:  Hayley K Charlton Hume; João Vidigal; Manuel J T Carrondo; Anton P J Middelberg; António Roldão; Linda H L Lua
Journal:  Biotechnol Bioeng       Date:  2018-12-31       Impact factor: 4.530

8.  Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells.

Authors:  Florian Strobl; Sahar Masoumeh Ghorbanpour; Dieter Palmberger; Gerald Striedner
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379

9.  Insect High Five™ cell line development using site-specific flipase recombination technology.

Authors:  Mafalda M Dias; João Vidigal; Daniela P Sequeira; Paula M Alves; Ana P Teixeira; António Roldão
Journal:  G3 (Bethesda)       Date:  2021-08-07       Impact factor: 3.154

Review 10.  Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases.

Authors:  Hasnat Tariq; Sannia Batool; Saaim Asif; Mohammad Ali; Bilal Haider Abbasi
Journal:  Front Microbiol       Date:  2022-01-03       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.